Testing effectiveness (Phase 2)Looking for participantsNCT05905328
What this trial is testing
Study of CTO1681 for the Prevention and Treatment of CRS in DLBCL Patients Receiving CAR T-Cell Therapy
Who this might be right for
Cytokine Release Syndrome
CytoAgents, Inc. 54